AbbVie (ABBV) Operating Income (2012 - 2026)
AbbVie (ABBV) posted Operating Income of $6.27 billion for Q3 2026, up 229.1% from $1.9 billion a year earlier but down 2.6% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Operating Income (2012 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Operating Income at AbbVie was $21.23 billion, up 134.9% year-over-year; for FY2025, it was $15.08 billion, up 65.0% from FY2024.
- Annual Operating Income shows a five-year compound annual growth rate of 5.8% (FY2020 to FY2025).
- In prior years, AbbVie's Operating Income was $9.14 billion in FY2024 (-28.4%), $12.76 billion in FY2023 (-29.6%), $18.12 billion in FY2022 (+1.1%) and $17.92 billion in FY2021 (+57.7%).
- Quarterly Operating Income has run from a low of -$1.49 billion in Q4 2024 to a high of $6.43 billion in Q2 2026 over five years.
- On a year-over-year basis, Operating Income has increased in each of the last three quarters, with growth averaging 45.5% over the last six quarters.
- The strongest year-over-year quarter for Operating Income in the past five years was Q3 2026, with growth of 229.1%; the weakest was Q3 2023, with a decline of 50.4%.
- According to Business Quant data, Operating Income for the three prior quarters was $6.43 billion (Q2 2026), $3.99 billion (Q1 2026) and $4.54 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 712.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.27 Bn |
| Jun 30, 2026 | 6.43 Bn |
| Mar 31, 2026 | 3.99 Bn |
| Dec 31, 2025 | 4.54 Bn |
| Sep 30, 2025 | 1.90 Bn |
| Jun 30, 2025 | 4.89 Bn |
| Mar 31, 2025 | 3.73 Bn |
| Dec 31, 2024 | -1.49 Bn |
| Sep 30, 2024 | 3.83 Bn |
| Jun 30, 2024 | 4.00 Bn |
| Mar 31, 2024 | 2.80 Bn |
| Dec 31, 2023 | 3.20 Bn |
| Sep 30, 2023 | 2.28 Bn |
| Jun 30, 2023 | 4.51 Bn |
| Mar 31, 2023 | 2.77 Bn |
| Dec 31, 2022 | 5.50 Bn |
| Sep 30, 2022 | 4.60 Bn |
| Jun 30, 2022 | 3.30 Bn |
| Mar 31, 2022 | 4.72 Bn |
| Dec 31, 2021 | 5.07 Bn |
API Access
AbbVie Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();